Published in Trends Pharmacol Sci on July 01, 1994
Dopamine and retinal function. Doc Ophthalmol (2004) 3.21
A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A (1998) 2.00
Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology (Berl) (2005) 1.54
The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking. Prog Neurobiol (2009) 1.48
The stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology (2010) 1.30
Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex. J Neurosci (2012) 1.25
Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol (2009) 1.18
D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci (2008) 1.09
Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. Proc Natl Acad Sci U S A (2001) 1.09
Disruption of conditioned reward association by typical and atypical antipsychotics. Pharmacol Biochem Behav (2010) 1.09
The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism. Sleep Med Rev (2012) 1.07
Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study. J Neurol Neurosurg Psychiatry (1997) 1.05
Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Ther (2010) 1.02
Dopaminergic agonists that result in ocular growth inhibition also elicit transient increases in choroidal thickness in chicks. Exp Eye Res (2010) 1.02
The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations. Psychopharmacology (Berl) (2012) 1.01
Neurobiological background of negative symptoms. Eur Arch Psychiatry Clin Neurosci (2015) 1.00
Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes. Br J Pharmacol (2000) 0.96
Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. Proc Natl Acad Sci U S A (2004) 0.96
Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate. J Neurosci (2009) 0.95
Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area. J Pharmacol Exp Ther (2010) 0.94
Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells. Br J Pharmacol (1999) 0.94
Dopamine-dependent tuning of striatal inhibitory synaptogenesis. J Neurosci (2010) 0.92
Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus. J Neurosci (2011) 0.91
Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells. Br J Pharmacol (1999) 0.91
Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata. J Physiol (1998) 0.91
Molecular genetics of schizophrenia: a critical review. J Psychiatry Neurosci (2003) 0.89
Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors. Biochem J (1995) 0.87
Beyond dopamine: glutamate as a target for future antipsychotics. ISRN Pharmacol (2012) 0.86
Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain. Neurochem Res (2008) 0.86
Dopamine D4 receptors in psychostimulant addiction. Adv Pharmacol (2014) 0.86
Genetic influences on smoking: candidate genes. Environ Health Perspect (1998) 0.86
Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity. Psychopharmacology (Berl) (2009) 0.85
Microglial responses to dopamine in a cell culture model of Parkinson's disease. Neurobiol Aging (2008) 0.85
Attenuation of the effects of d-amphetamine on interval timing behavior by central 5-hydroxytryptamine depletion. Psychopharmacology (Berl) (2008) 0.84
Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats. Neuropharmacology (2011) 0.84
D1-like dopamine receptor activation modulates GABAergic inhibition but not electrical coupling between neocortical fast-spiking interneurons. J Neurosci (2008) 0.84
Effect of quinpirole on timing behaviour in the free-operant psychophysical procedure: evidence for the involvement of D2 dopamine receptors. Psychopharmacology (Berl) (2007) 0.83
Medial prefrontal cortex lesions impair decision-making on a rodent gambling task: reversal by D1 receptor antagonist administration. Behav Brain Res (2013) 0.83
Dopamine Receptors and Neurodegeneration. Aging Dis (2015) 0.83
A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes. J Psychiatry Neurosci (1996) 0.83
Evidence for a role of D1 dopamine receptors in d-amphetamine's effect on timing behaviour in the free-operant psychophysical procedure. Psychopharmacology (Berl) (2006) 0.82
Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders. Paediatr Drugs (2014) 0.82
Dopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitro. Neurocrit Care (2008) 0.82
Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors. Behav Brain Res (2016) 0.81
Effects of haloperidol on cue-induced autonomic and behavioral indices of heroin reward and motivation. Psychopharmacology (Berl) (2002) 0.81
Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.81
Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels. Pflugers Arch (2003) 0.81
Dopamine D(3) receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice. Neuropharmacology (2013) 0.81
YKP1447, A Novel Potential Atypical Antipsychotic Agent. Korean J Physiol Pharmacol (2009) 0.81
Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys. J Neurophysiol (2011) 0.81
Inhibition of ATP-sensitive potassium channels by haloperidol. Br J Pharmacol (2004) 0.80
Central manipulation of dopamine receptors attenuates the orexigenic action of ghrelin. Psychopharmacology (Berl) (2013) 0.80
The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. Br J Pharmacol (2013) 0.80
Amphioxus expresses both vertebrate-type and invertebrate-type dopamine D(1) receptors. Invert Neurosci (2010) 0.79
Effects of sigma ligands on the cloned mu-, delta- and kappa-opioid receptors co-expressed with G-protein-activated K+ (GIRK) channel in Xenopus oocytes. Br J Pharmacol (1996) 0.79
Selective modulation of GABAergic tonic current by dopamine in the nucleus accumbens of alcohol-dependent rats. J Neurophysiol (2014) 0.79
Identification of a new selective dopamine D4 receptor ligand. Bioorg Med Chem (2014) 0.79
Fast phasic release properties of dopamine studied with a channel biosensor. J Neurosci (2014) 0.79
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. BMC Neurosci (2006) 0.79
The neuropharmacology of psychosis. Schizophr Bull (2007) 0.78
Plasticity in D1-like receptor expression is associated with different components of cognitive processes. PLoS One (2012) 0.78
Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys. J Neurophysiol (2014) 0.78
The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78
Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells. Br J Pharmacol (2000) 0.78
The genetic effects of the dopamine D1 receptor gene on chicken egg production and broodiness traits. BMC Genet (2010) 0.77
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? J Psychiatry Neurosci (2001) 0.77
Quantitative comparison of functional screening by measuring intracellular Ca2+ with radioligand binding at recombinant human dopamine receptors. AAPS PharmSci (2002) 0.77
NMR Metabolomics Analysis of Parkinson's Disease. Curr Metabolomics (2015) 0.77
Hyperprolactinaemia with amisulpride. Indian J Psychiatry (2008) 0.76
Gene-environment interactions affect long-term depression (LTD) through changes in dopamine receptor affinity in Snap25 deficient mice. Brain Res (2013) 0.76
Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response. Neuropharmacology (2013) 0.76
Dopaminergic modulation of distracter-resistance and prefrontal delay period signal. Psychopharmacology (Berl) (2014) 0.76
Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.76
Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions. BMC Musculoskelet Disord (2011) 0.76
An endogenous 5-HT(7) receptor mediates pigment granule dispersion in Xenopus laevis melanophores. Br J Pharmacol (2001) 0.76
Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia. J Psychiatry Neurosci (2003) 0.76
Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration. J Neural Transm (Vienna) (1997) 0.76
Binding of Sulpiride to Seric Albumins. Int J Mol Sci (2016) 0.75
The Gordon Wilson Lecture. Decade of the brain: advances and hopes at the midpoint. Trans Am Clin Climatol Assoc (1997) 0.75
Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats. Neurotox Res (2015) 0.75
Dopamine D1 receptor blockade impairs alcohol seeking without reducing dorsal striatal activation to cues of alcohol availability. Brain Behav (2015) 0.75
Identification of the Beer Component Hordenine as Food-Derived Dopamine D2 Receptor Agonist by Virtual Screening a 3D Compound Database. Sci Rep (2017) 0.75
Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats. Br J Pharmacol (2012) 0.75
Effects of SKF83959 on the excitability of hippocampal CA1 pyramidal neurons: a modeling study. Acta Pharmacol Sin (2014) 0.75
Blocking Dopaminergic Signaling Soon after Learning Impairs Memory Consolidation in Guinea Pigs. PLoS One (2015) 0.75
Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia. Acta Pharmacol Sin (2016) 0.75
The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics. J Mol Model (2016) 0.75
Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture. J Neural Transm (Vienna) (2005) 0.75
The newer, 'atypical' antipsychotic drugs--their development and current therapeutic use. Br J Gen Pract (1999) 0.75
Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice. Sci Rep (2017) 0.75
Alcohol-induced behavioral changes in zebrafish: The role of dopamine D2-like receptors. Psychopharmacology (Berl) (2016) 0.75
Induction of tolerance of dopaminergic responses in man. J Neural Transm (Vienna) (2008) 0.75
Myopia induced by flickering light in guinea pig eyes is associated with increased rather than decreased dopamine release. Mol Vis (2017) 0.75
Cloning and expression of a rat D2 dopamine receptor cDNA. Nature (1989) 3.59
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem (1995) 3.08
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41
Dopamine D4 receptors elevated in schizophrenia. Nature (1993) 2.09
A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet (1993) 2.09
Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride. J Neurochem (1995) 2.03
The dopamine D(4) receptor: one decade of research. Eur J Pharmacol (2000) 1.69
Cloning and expression of human and rat D1 dopamine receptors. Nature (1990) 1.65
Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem (1990) 1.63
Dopamine receptor genes: new tools for molecular psychiatry. J Psychiatry Neurosci (1992) 1.53
Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J (1990) 1.25
Quantitation of vasopressin mRNA and oxytocin mRNA in hypothalamic nuclei by solution hybridization assays. J Neurochem (1986) 1.22
Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1989) 1.17
Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics (1999) 1.16
Molecular biology of the dopamine receptors. Eur J Pharmacol (1991) 1.14
Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol (1994) 1.14
SH3 binding domains in the dopamine D4 receptor. Biochemistry (1998) 1.06
Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology (1997) 0.99
Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor. Mol Pharmacol (2001) 0.98
Oxytocin gene expression in discrete hypothalamic magnocellular cell groups is stimulated by prolonged salt loading. Endocrinology (1987) 0.97
Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology (1994) 0.97
Genomic organization and promoter analysis of the human G-protein-coupled K+ channel Kir3.1 (KCNJ3/HGIRK1). Genomics (1997) 0.91
Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand. Eur J Pharmacol (1995) 0.91
Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg (1993) 0.89
Dopamine receptors labelled by PHNO. Synapse (1993) 0.89
Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. J Psychiatr Res (1997) 0.89
Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology (Berl) (1999) 0.88
Transcription of a human dopamine D5 pseudogene. Biochem Biophys Res Commun (1991) 0.86
Cloning of a G protein-activated inwardly rectifying potassium channel from human cerebellum. Brain Res Mol Brain Res (1996) 0.86
A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6. Proc Natl Acad Sci U S A (1992) 0.86
Schizophrenia as a brain disease. The dopamine receptor story. Arch Neurol (1993) 0.85
Serotonin receptor cDNA cloned from Lymnaea stagnalis. Proc Natl Acad Sci U S A (1993) 0.85
Co-expression of human Kir3 subunits can yield channels with different functional properties. Cell Signal (1999) 0.84
Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma. Proc Natl Acad Sci U S A (1990) 0.83
The D4 dopamine receptor gene maps on 11p proximal to HRAS. Genomics (1993) 0.83
Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Eur J Pharmacol (1998) 0.82
Dopamine receptors and antipsychotic drug response. Br J Psychiatry Suppl (1993) 0.82
Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism. Jpn J Pharmacol (1996) 0.82
Role of dopamine D2, D4 and serotonin(2A) receptors in antipsychotic and anticataleptic action. J Psychopharmacol (1997) 0.81
Dopamine D4 receptor variant in Africans, D4valine194glycine, is insensitive to dopamine and clozapine: report of a homozygous individual. Am J Med Genet (1996) 0.81
The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. Eur J Pharmacol (1992) 0.80
Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia. Am J Med Genet (1994) 0.80
Diurnal variation in vasopressin and oxytocin messenger RNAs in hypothalamic nuclei of the rat. Brain Res (1988) 0.80
A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett (1993) 0.80
Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells. Eur J Pharmacol (2001) 0.80
Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes. J Clin Psychopharmacol (1988) 0.80
Association study between the dopamine D4 receptor gene and schizophrenia. Am J Med Genet (1995) 0.79
Alleles at the dopamine D4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred. Am J Med Genet (1993) 0.79
Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline. Synapse (1997) 0.79
Immunological studies with a monoclonal antibody suggest a different conformation of neurophysin in parvicellular neurons of rat hypothalamus. Brain Res (1990) 0.78
Schizophrenia: normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2. Neuropsychopharmacology (1993) 0.78
Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20. Mol Pharmacol (1993) 0.78
Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride. Eur J Pharmacol (1995) 0.77
A HincII RFLP in the human D4 dopamine receptor locus (DRD4). Nucleic Acids Res (1991) 0.77
Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse (1993) 0.77
Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation. Endocrinology (1997) 0.77
Dopamine D4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective. Eur J Pharmacol (1993) 0.76
Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats. Eur J Pharmacol (1995) 0.76
A PstI restriction fragment length polymorphism in the 5' untranslated region of DRD4 is not associated with schizophrenia. Psychiatr Genet (1996) 0.76
Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors. J Med Chem (1994) 0.75
Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism. Adv Pharmacol (1998) 0.75
SH3 ligands in the dopamine D3 receptor. Cell Signal (2001) 0.75
Vasopressin gene expression is attenuated in the fetal Brattleboro rat. FEBS Lett (1986) 0.75
Cryptic initiation at the human D4 receptor reveals a functional role for the amino terminus. Biochemistry (1996) 0.75
(G)n-mononucleotide polymorphism in the human D4 dopamine receptor (DRD4) gene. Hum Genet (1994) 0.75
Identification of N alpha-acetyl-alpha-endorphin and N alpha-acetyl-gamma-endorphin isolated from the neurointermediate lobe of the rat pituitary gland. J Biol Chem (1985) 0.75
Dopamine receptor gene transfer into rat striatum using a recombinant adenoviral vector: rotational behaviour. Neurosci Lett (2000) 0.75
Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors. Synapse (1994) 0.75
Promoter-independent regulation of cell-specific dopamine receptor expression. FEBS Lett (1998) 0.75
Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors. J Med Chem (1995) 0.75
Functional characterization of the human dopamine D4.2 receptor using vaccinia virus as an expression system. Eur J Pharmacol (1995) 0.75
Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred. Arch Gen Psychiatry (1994) 0.75
Schizophrenia: dopamine D1 receptor sequence is normal, but has DNA polymorphisms. Neuropsychopharmacology (1993) 0.75
A SmaI PCR-RFLP in the 5' noncoding region of the human D4 dopamine receptor gene (DRD4). Hum Hered (1994) 0.75
Quantitation of vasopressin and oxytocin mRNA levels in the brain. Methods Enzymol (1989) 0.75